REFERENCES
- Agis H, Weltermann A, Mitterbauer G. Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia. Ann Hematol. 1999; 78: 329–332, [PUBMED], [INFOTRIEVE], [CSA]
- Akao Y, Yamada H, Nakagawa Y. Arsenic-induced apoptosis in malignant cells in vitro. Leuk Lymphoma. 2000; 37: 53–63, [PUBMED], [INFOTRIEVE], [CSA]
- Akao Y, Nakagawa Y, Akiyama K. Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. FEBS Lett. 1999; 455: 59–62, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bian X, Giordano T D, Lin H J, Solomon G, Castle V P, Opipari A W, Jr. Chemotherapy-induced apoptosis of S-type neuroblastoma cells requires caspase-9 and is augmented by CD95/Fas stimulation. J Biol Chem. 2004; 279: 4663–4669, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cai X, Chen G, Jia P. The mechanisms of arsenic trioxide-induced apoptosis in hematopoietic malignant cells. Zhonghua Yi Xue Za Zhi. 1999; 79: 452–425, [PUBMED], [INFOTRIEVE], [CSA]
- Evens A M, Tallman M S, Gartenhaus R B. The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future. Leuk Res. 2004; 28: 891–900, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zuo L, Li J, Shen T, Zhang Z N. The comparison between the mechanisms of sodium selenite induced apoptosis and arsenic trioxide induced apoptosis in human acute promyelocytic leukemia cell line NB4 cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2002; 10: 195–200, [PUBMED], [INFOTRIEVE], [CSA]
- Li X, Ding X, Adrian T E. Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells. Cancer Invest. 2004; 22: 389–400, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McCafferty-Grad J, Bahlis N J, Krett N. Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells. Mol Cancer Ther. 2003; 2: 1155–1164, [PUBMED], [INFOTRIEVE], [CSA]
- Woo S H, Park I C, Park M J. Arsenic trioxide sensitizes CD95/Fas-induced apoptosis through ROS-mediated upregulation of CD95/Fas by NF-kappaB activation. Int J Cancer. 2004; 112: 596–606, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kitamura K, Minami Y, Yamamoto K. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia. 2000; 14: 1743–1750, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chen Y C, Lin-Shiau S Y, Lin J K. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol. 1998; 177: 324–333, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Karlsson J, Porn-Ares I, Pahlman S. Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53. Clin Cancer Res. 2004; 10: 3179–3188, [PUBMED], [INFOTRIEVE], [CSA]
- Davidoff A N, Mendelow B V. Unexpected cytokinetic effects induced by puromycin include a G2-arrest, a metaphase-mitotic-arrest, and apoptosis. Leuk Res. 1992; 16: 1077–1085, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gallagher R E. Arsenic—new life for an old potion. N Engl J Med. 1998; 339: 1389–1391, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fojo T, Bates S. Arsenic trioxide (As(2)O(3)): still a mystery. Cell Cycle. 2002; 1: 183–186, [PUBMED], [INFOTRIEVE], [CSA]
- Wang Z Y. Arsenic compounds as anticancer agents. Cancer Chemother Pharmacol. 2001; 48: S72–S76, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]